1
项与 Autologous CD30 CAR-T(Shanxi Bethune Hospital) 相关的临床试验Clinical Study on the Safety and Efficacy of Chimeric Antigen Receptor Gene Modified T Cells Targeting CD30 in the Treatment of CD30 Positive Relapsed/Refractory Lymphoma
The is a prospective, open-label, dose-climbing clinical study assessing the efficacy and safety of CD30 CAR-T in the treatment of r/r CD30+ lymphoma. Plan to recruit 15 subjects with r/r CD30+ lymphoma。
100 项与 Autologous CD30 CAR-T(Shanxi Bethune Hospital) 相关的临床结果
100 项与 Autologous CD30 CAR-T(Shanxi Bethune Hospital) 相关的转化医学
100 项与 Autologous CD30 CAR-T(Shanxi Bethune Hospital) 相关的专利（医药）
100 项与 Autologous CD30 CAR-T(Shanxi Bethune Hospital) 相关的药物交易
